text_en

Meet Idyllic and Picturesque Deqing

A three-minute video featuring the county of Deqing, Huzhou City, east China’s Zhejiang Province, has become a hit recently on social media, attracting attention from netizens both at home and abroad. “Meet Idyllic and Picturesque Deqing”, posted on the accounts @Hi Deqing on Facebook and Twitter recently, depicts Deqing’s striking landscape scenery and county views, which […]

thaipr.net

22 ธ.ค. 64

CSTONE ANNOUNCED NEW DRUG APPROVAL OF CEJEMLY® (SUGEMALIMAB) IN CHINA TO POTENTIALLY RESHAPE THE LANDSCAPE OF IMMUNO-ONCOLOGY THERAPY IN LUNG CANCER

CStone Pharmaceuticals (the “Company” or “CStone“) is pleased to announce that the National Medical Products Administration (“NMPA“) of China has approved the new drug application (“NDA“) of anti-PD-L1 monoclonal antibody Cejemly® (sugemalimab) in combination with chemotherapy for treatment-naïve metastatic (stage IV) non-small cell lung cancer (“non-small cell lung caner” or…

thaipr.net

21 ธ.ค. 64

Venture Global LNG and CNOOC Gas & Power Announce LNG Sales and Purchase Agreements

Today, Venture Global LNG and CNOOC Gas & Power Group Co., Ltd., a wholly owned subsidiary of China National Offshore Oil Corporation (CNOOC), announced the execution of a 20-year Sales and Purchase Agreement (SPA). This marks the first LNG supply agreement signed by a US exporter with CNOOC, China’s largest importer of LNG. Under the deal, Venture Global will […]

thaipr.net

21 ธ.ค. 64

World Health Organization Grants Second Emergency Use Listing for Novavax COVID-19 Vaccine

– Nuvaxovid™ COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]) listed for emergency use by the WHO – EUL for Nuvaxovid complements listing for Novavax vaccine manufactured and marketed by Serum Institute of India as Covovax™ – EUL by WHO is a prerequisite for exports to numerous countries participating in the COVAX Facility Novavax, Inc. (Nasdaq: NVAX), a biotechnology company […]

thaipr.net

21 ธ.ค. 64

European Commission Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine

Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) is the first protein-based COVID-19 vaccine authorized for use in Europe Novavax and the European Commission previously announced an advance purchase agreement for up to 200 million doses through 2023 Authorization follows positive recommendation by European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) Novavax, Inc. (Nasdaq: NVAX), […]

thaipr.net

21 ธ.ค. 64

Novavax Receives Positive European Medicines Agency Recommendation for Conditional Marketing Authorization of its COVID-19 Vaccine

European Commission decision on conditional marketing authorization expected imminently Upon authorization, Nuvaxovid™ (also known as NVX-CoV2373) will be the first protein-based COVID-19 vaccine available in Europe Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the European Medicines Agency (EMA) has…

thaipr.net

21 ธ.ค. 64

Turing Achieves Unicorn Status Following Series D Bringing Total Raised to Over $140 Million

Intelligent Talent Cloud Company, Turing, Crosses $1 Billion Valuation Turing, the world’s leading Intelligent Talent Cloud, announced today it has attained unicorn status after raising $87 million at a valuation of about $1.1 billion. The Series D financing was led by WestBridge Capital with participation from Foundation Capital, along with new investor StepStone Group. WestBridge […]

thaipr.net

21 ธ.ค. 64
1 … 504 505 506 507 508 … 764

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.